Medication info
PMS Memantine Tablet 10mg (Memantine Hydrochloride)

PMS Memantine Tablet 10mg (Memantine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Memantine Hydrochloride›10mg / 1 tablet
Manufacturer / importer
Genupharm Co., Ltd.
Appearance
White oblong film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201601050 · Approved 2016.02.25 · Insurance code 698003070

Summary

Main use
Treatment of moderate to severe Alzheimer's disease
Who takes it
Adults
Adult dose
This medicine is administered orally once daily, at the same time each day. If necessary, it may be administered twice daily. It may be taken with or without food. Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows until the maintenance dose is reached. Week 1 (days 1–7): Administer 5mg once daily for 7 days. Week 2 (days 8–14): Administer 10mg once daily for 7 days. Week 3 (days 15–21): Administer 15mg once daily for 7 days. From week 4 onward: Administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. The recommended dose for elderly patients aged 65 years and older is 20mg once daily. No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), the daily dose should be reduced to 10mg. If well tolerated, the dose may be increased to 20mg once daily at least 7 days after starting treatment, following the standard dose-escalation schedule. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), the daily dose should be reduced to 10mg. No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). As there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine to these patients.

Ingredients

Manufacturer
Genupharm Co., Ltd.

Efficacy & effects

Treatment of moderate to severe Alzheimer's disease

  • Alzheimer's disease
View approved original text

This medication is used in patients with moderate to severe Alzheimer's disease. It helps to improve cognitive function decline and the ability to perform daily activities caused by Alzheimer's disease. It is effective in maintaining or enhancing patients' memory, judgment, and daily behavioral abilities. This drug contributes to alleviating Alzheimer's disease symptoms and improving the quality of life for patients. It is primarily suitable for patients in the moderate to severe stage and helps improve neurological function. Therefore, it is used in the treatment of moderate to severe Alzheimer's disease.

How to take

Adult dose

This medicine is administered orally once daily, at the same time each day. If necessary, it may be administered twice daily. It may be taken with or without food. Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows until the maintenance dose is reached. Week 1 (days 1–7): Administer 5mg once daily for 7 days. Week 2 (days 8–14): Administer 10mg once daily for 7 days. Week 3 (days 15–21): Administer 15mg once daily for 7 days. From week 4 onward: Administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. The recommended dose for elderly patients aged 65 years and older is 20mg once daily. No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), the daily dose should be reduced to 10mg. If well tolerated, the dose may be increased to 20mg once daily at least 7 days after starting treatment, following the standard dose-escalation schedule. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), the daily dose should be reduced to 10mg. No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). As there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine to these patients.

Precautions

This drug should not be used in patients with hypersensitivity to its components or those with severe liver or kidney dysfunction. Patients with epilepsy or those who have had seizures in the past should use this drug cautiously, and co-administration with certain NMDA antagonists should be avoided as it may increase side effects. Patients with dietary changes or conditions that may cause acid-base disturbance in urine should be monitored carefully. Patients with recent heart-related diseases or uncontrolled hypertension should be cautious as the safety of this drug has not been fully confirmed. During the use of this medication, side effects such as dizziness, headache, constipation, drowsiness, and hypertension may occur, so if any abnormal symptoms arise, consultation with a healthcare professional is necessary. This drug may interact with other medications, so it is important to inform the doctor, especially if taking NMDA antagonists, antipsychotics, antihypertensives, or anticoagulants. Women who are pregnant or breastfeeding should consult a doctor before taking this medication, and it is recommended to suspend breastfeeding if taking the drug during lactation. The safety in children or adolescents under the age of 18 has not been confirmed; therefore, it is preferable not to use in this age group. In case of overdose, symptoms such as confusion, drowsiness, hallucinations, and seizures may occur, and immediate medical attention should be sought for appropriate treatment. This drug may affect the central nervous system, so caution is required when driving or operating machinery. Finally, keep this medication out of reach of children and ensure it is not transferred to other containers.

Side effects

  • Dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • fungal infection
  • drug allergy
  • confusion
  • hallucination
  • psychiatric reaction
Show 23 more
  • balance disorder
  • gait abnormality
  • seizures
  • heart failure
  • venous thrombosis/thromboembolism
  • dyspnea
  • vomiting
  • pancreatitis
  • elevated liver function test levels
  • hepatitis
  • fatigue
  • nonspecific fatigue
  • weakness
  • diarrhea
  • agitation
  • aggressiveness
  • stupor
  • unconsciousness
  • restlessness
  • psychosis
  • visual hallucination
  • double vision
  • coma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is advisable to maintain the storage temperature between 1 to 30 degrees Celsius at room temperature. This way, the drug's efficacy and safety can be well preserved.

Appearance and packaging

Appearance

White oblong film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.